Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified — this company's full, act-by-act verified dossier is still being assembled.
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of EB Pharma Developments is 0.9% (low). The 2025 annual accounts show equity of €5k and a net result of €-1k. Equity is shrinking by ~27% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2027. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 4 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Trust signals
3 signalsAdministrative Flags
0 eventsCompany registry (CBE)
Crossroads Bank| Legal nameNL | EB Pharma Developments |